Assessment of leech therapy for knee osteoarthritis: a randomized study
Andereya S, Stanzel S, Maus U, Mueller-Rath R, Mumme T, Siebert CH, Stock F, Schneider U (2008) · Acta Orthopaedica · n=113
Study Profile
- Design
- single-center, three-arm randomized study with patient blinding via 'artificial leech' simulated control (Aachen University Hospital)
- Sample size (n)
- 113
- Intervention
- Single application of leeches (group I, n=38) or double application 4 weeks apart (group II, n=35); Hirudo medicinalis periarticularly at the symptomatic knee
- Comparator
- Control group (n=40) treated with an 'artificial leech' simulation device, with treatment blinded as far as feasible
- Primary endpoint
- KOOS and WOMAC scores plus VAS pain, monitored over 26 weeks with intake of pain medication tracked
- Primary result
- All three groups showed improvement in KOOS, WOMAC, and VAS pain after intervention; improvements were statistically significant for treatment groups I and II throughout the 26-week follow-up; greatest improvement seen in the double-treatment group with long-term reduction of joint stiffness and improved activities of daily living
- Follow-up duration
- 26 weeks
- PMID
- 18484250
Key Findings
- First leech-OA RCT to include patient blinding via an 'artificial leech' simulated control arm
- Three-arm design (single application n=38, double application n=35, artificial-leech control n=40) tested both dose-response and blinding
- Repeated leech treatment (group II) produced the greatest long-term improvement in joint stiffness and activities of daily living
- Authors explicitly acknowledged that the positive outcomes could reflect active substances, placebo effect, or expectation effects — methodologically honest about residual uncertainty
- Reduction in pain medication intake statistically significant for both leech treatment arms over 26 weeks
Limitations
- Sham control fidelity uncertain — 'artificial leech' design may not have fully blinded patients to allocation
- Single center (Aachen) — same investigators as 2006 pilot and 2008 hyaluronic-acid trial, raising investigator-site dependence concerns
- Authors explicitly note inability to distinguish biological from expectancy effects
- 26-week follow-up still leaves long-term durability beyond 6 months unanswered
- Three-arm allocation reduced per-arm power versus a two-arm superiority design
Clinical Implications
Andereya 2008 (Acta Orthopaedica) is methodologically the strongest of the early German leech-OA RCTs because it included an 'artificial leech' control intended to address the blinding limitation of Michalsen 2003 and the Aachen 2008 HA comparison. The trial confirms a robust effect of repeated leech therapy on KOOS, WOMAC and VAS pain in moderate-to-advanced knee OA at 26 weeks, while honestly acknowledging that the trial cannot fully separate biological from placebo effects. The result motivated the subsequent Hohmann 2014 plantar-fasciitis sham trial and the ongoing ELECT trial which uses a fully validated sham device. Clinicians should cite Andereya 2008 (Acta Orthopaedica) when discussing the question of whether the leech-OA effect persists under blinded conditions — the answer suggested here is yes, but with the methodological caveat that perfect blinding remains aspirational.
Related Trials
Effectiveness of leech therapy in osteoarthritis of the knee: a randomized, controlled trial
Michalsen A, Klotz S, Lüdtke R, Moebus S, Spahn G, Dobos GJ (2003)
Leech therapy for symptomatic treatment of knee osteoarthritis: results and implications of a pilot study
Michalsen A, Moebus S, Spahn G, Esch T, Langhorst J, Dobos GJ (2002)
Effectiveness of topical gel of medical leech (Hirudo medicinalis) saliva extract on patients with knee osteoarthritis: a randomized clinical trial
Shakouri A, Adljouy N, Balkani S, Mohamadi M, Hamishehkar H, Abdolalizadeh J, Kazem Shakouri S (2017)
Randomised controlled trial with medical leeches for osteoarthritis of the knee
Stange R, Moser C, Hopfenmueller W, Mansmann U, Buehring M, Uehleke B (2012)